Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program

<jats:sec><jats:title>Objectives</jats:title><jats:p>To determine the effects of a lifestyle intervention on the development of type 2 diabetes mellitus (T2DM) among participants with impaired glucose tolerance (IGT), in particular in the subgroup with baseline glycated hemoglobin (HbA1c) levels ≥5.7%, in primary healthcare settings.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Randomized controlled trial.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>32 healthcare centers in Japan.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Participants with IGT, aged 30–60 years, were randomly assigned to either an intensive lifestyle intervention group (ILG) or a usual care group (UCG).</jats:p></jats:sec><jats:sec><jats:title>Interventions</jats:title><jats:p>During the initial 6 months, participants in the ILG received four group sessions on healthy lifestyles by public health providers. An individual session was further conducted biannually during the 3 years. Participants in the UCG received usual care such as one group session on healthy lifestyles.</jats:p></jats:sec><jats:sec><jats:title>Outcome measures</jats:title><jats:p>The primary endpoint was the development of T2DM based on an oral glucose tolerance test.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The mean follow-up period was 2.3 years. The annual incidence of T2DM were 2.7 and 5.1/100 person-years of follow-up in the ILG (n=145) and UCG (n=149), respectively. The cumulative incidence of T2DM was significantly lower in the ILG than in the UCG among participants with HbA1c levels ≥5.7% (log-rank=3.52, p=0.06; Breslow=4.05, p=0.04; Tarone-Ware=3.79, p=0.05), while this was not found among participants with HbA1c levels <5.7%.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Intensive lifestyle intervention in primary healthcare setting is effective in preventing the development of T2DM in IGT participants with HbA1c levels ≥5.7%, relative to those with HbA1c levels <5.7%.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p>UMIN000003136.</jats:p></jats:sec>